Latest News about Briefs
Recent news which mentions Briefs
Pfizer, BioNTech's COVID-19/Flu Combo Vaccine Fails To Meet Key Goal In Late-Stage Study
August 16, 2024
From Benzinga
From Benzinga
Disney Park Prices Skyrocket, New Attractions Promise More Value
August 16, 2024
From Benzinga
Florida Ruling Upholds GSK's Stance On Once Popular Heart Burn Drug Zantac Not Being Associated With Cancer Risk
August 16, 2024
From Benzinga
Carrier Global Sells Commercial And Residential Fire Business For $3B, Proceeds To Be Utilized For Stock Buybacks
August 16, 2024
From Benzinga
FDA Approves AstraZeneca's Blockbuster Cancer Drug, Imfinzi, In Combination With Chemo For Non-Small Cell Lung Cancer
August 16, 2024
From Benzinga
What's Going On With Rocket Lab Stock Today?
August 16, 2024
From Benzinga
From Benzinga
EXCLUSIVE: La Rosa's Q2 Revenue Jumps 154%, Expects $100M Annualized Revenue by 2024
August 16, 2024
From Benzinga
Why Is Texas Instruments Stock Rising Today?
August 16, 2024
From Benzinga
Singapore's PropertyGuru Agrees To Be Taken Private By EQT AB In $1.1B Deal: Details
August 16, 2024
From Benzinga
From Benzinga
Stellantis Under Fire: Shareholders Reportedly Sue Company For Inflated Stock Price Claims
August 16, 2024
Tickers
STLA
From Benzinga
What's Going On With Kroger Stock Premarket Friday?
August 16, 2024
From Benzinga
From Benzinga
PNC Financial Upgraded: Analyst Highlights Company's Ability To Capitalize Opportunities From Market Dislocations
August 15, 2024
From Benzinga
From Benzinga
Oral Vaccine Focused Penny Stock Vaxart Is 'Uniquely Positioned', Analyst Sees Almost 83% Upside
August 15, 2024
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Lumentum Set For Growth: Analysts See Strong Recovery Ahead With AI And Telecom Momentum
August 15, 2024
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
What's Going On With Nvidia Stock On Thursday?
August 15, 2024
From Benzinga
Turnstone Biologics Shifts Focus To 'High Unmet Medical Need' Cancers, Shares Initial Data From Colorectal Cancer Cell Therapy Study
August 15, 2024
From Benzinga
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.